Nanotech grant
This article was originally published in The Tan Sheet
Executive Summary
The National Institutes of Health awards a $1.6 million Research Project Grant to Luna Innovations to investigate the efficacy of fullerene-based nanomedicines in treating allergies and other inflammatory conditions, according to a July 22 release. Roanoke, Va.-based Luna says it modified fullerenes, a class of carbon molecules, to amplify the immune response in cells and "block the noxious effects of allergies." With the NIH funding, the health science developer intends to further explore systemic, cellular and molecular responses to fullerenes through in vivo and in vitro tests. NIH awarded the grant through its National Institute of General Medical Sciences and participates in the National Nanotechnology Initiative to evaluate nanomaterials (1"The Tan Sheet" Aug. 14, 2006, p. 7)...
You may also be interested in...
Task Force To Develop Approaches To Nanotechnology In Drugs, Foods
FDA's Nanotechnology Task Force will identify policy gaps related to the use of nanotechnology particles to evaluate possible adverse health effects from products that contain the materials, the agency said
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.